Post-splenectomy intrapancreatic accessory spleen mimicking endocrine tumor of the pancreas  by Zhu, Hong-xu et al.
P
e
H
D
a
A
R
R
A
A
K
I
P
S
P
1
1
f
s
t
l
t
a
d
a
a
f
I
s
C
h
2
(CASE  REPORT  –  OPEN  ACCESS
International Journal of Surgery Case Reports 5 (2014) 1151–1153
Contents lists available at ScienceDirect
International  Journal  of  Surgery  Case  Reports
journa l h omepage: www.caserepor ts .com
ost-splenectomy  intrapancreatic  accessory  spleen  mimicking
ndocrine  tumor  of  the  pancreas
ong-xu  Zhu,  Wen-hui  Lou,  Tian-tao  Kuang,  Dan-song  Wang ∗
epartment of General Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 10 September 2014
eceived in revised form 30 October 2014
ccepted 10 November 2014
vailable online 15 November 2014
eywords:
ntrapancreatic accessory spleen
ancreatic neuroendocrine tumor
plenectomy
ancreas
a  b  s  t  r  a  c  t
INTRODUCTION:  Intrapancreatic  accessory  spleen  is an uncommon  congenital  abnormality  of  the  spleen
with no indication  for  surgical  intervention.  Among  the few  cases  reported,  IPAS  coexisted  with  a normal
spleen.  We  here  report  the  ﬁrst  case  of  IPAS  arising  a couple  years  after  splenectomy  with  the  appearance
of an  endocrine  tumor  of  the  pancreas.
PRESENTATION  OF  CASE:  A 62-year-old  female  presented  with  a one-week  history  of left upper  quadrant
discomfort.  She  had  splenectomy  for  the  treatment  of  hypersplenism  caused  by  cirrhotic  portal  hyperten-
sion two years  before  this  admission.  Her  physical  examination  was  unremarkable  and laboratory  data
was within  the  normal  range.  Both  the  ultrasonography  and  magnetic  resonance  image  revealed  a  small
oval-shaped  mass  in  the tail  of  her  pancreas  with  the  diameter  2 cm  or  less.  A distal  pancreatectomy  was
performed  for the suspection  of  malignant  neuroendocrine  tumor  of the pancreas.  An  intrapancreatic
accessory  spleen  was conﬁrmed  by the  pathologic  examination.
DISCUSSION:  Intrapancreatic  accessory  spleen  is  one  kind  of congenital  ectopic  spleen  without  indication
for  operative  intervention.  We  present  the  case  to support  that  intrapancreatic  accessory  spleen  may
enlarge  through  a compensatory  mechanism,  and  raise  the  awareness  of this  intrapacreatic  entity to
avoid  unnecessary  surgical  operation.
CONCLUSION:  IPAS  should  be  highly  considered  as  a differential  diagnosis  while  the  lesion  is no more
than  2.5  cm in diameter  and/or  other  accessory  spleens  show  around  the splenic  hilum.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Background
.1. Introduction
Accessory spleen is a congenital defect which is caused by the
usion failure of the splenic anlage during embryology. As the name
uggests, it is called intrapancreatic accessory spleen (IPAS) when
he accessory spleen locates within the pancreas. IPAS is a benign
esion and rarely causes any symptom, and requires no surgical
reatment unless it is associated with hematological disorders such
s idiopathic thrombocytopenic purpura. Therefore it is crucial to
ifferentiate IPAS with neoplastic diseases of the pancreas. There
re only a few cases of IPAS reported according to the literature
nd most were identiﬁed only after surgical resection, which is per-
ormed for suspected endocrine tumor. Here we present a case of
PAS mimicking endocrine tumor of the pancreas with a history of
plenectomy.
∗ Corresponding author at: 180# Fenglin Road, Xuhui Area, Shanghai City 200032,
hina. Tel.: +86 13601675641.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1.2. Case presentation
A 62-year-old female with a history of hepatic cirrhosis and por-
tal hypertension for which she had been previously submitted to
surgery and had spleen removed. Cholecystectomy was  performed
for the treatment of cholecystolithiasis at the same time. Before
this admission, she presented with left upper quadrant discomfort
for one week. The patient had no other complaints, such as nausea,
vomiting, jaundice, or symptoms of hypoglycemia. Physical exami-
nation was unremarkable and laboratory data including peripheral
blood counts, blood glucose and tumor biomarkers was within the
normal range.
The ultrasonography to investigate her abdominal symptom
revealed a 17 mm × 15 mm hypoechoic mass posterior to the stom-
ach and superior to the left adrenal gland. The abdominal magnetic
resonance image (MRI) further conﬁrmed the 16 mm × 12 mm
lesion in the pancreatic tail. Compared with the pancreatic tissue,
the intrapancreatic mass presented lower intensity on T1-weighed
MRI  and higher intensity on both T2 and diffused weighed images
(Fig. 1). The lesion showed persisting enhancement during the
late phases of dynamic MRI  study. An extensive serum pancreatic
hormone screen showed hormone levels within the normal limit
after admission to our department. The computed tomography (CT)
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Radiologic examination results. An intrapancreatic mass presented lower intensi
MRI  study. The CT scans detected no intrapancreatic space-occupying lesion after her spl
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differentiation between the two  kind of lesions. Compared with theig. 2. Histologic staining of the mass showing a spleen surrounded by pancreatic
issue (H&E stain, original magniﬁcation 40×).
cans after her splenectomy two years ago were also reviewed
nd no bump was shown on both of the plain and enhanced
cans (Fig. 1). Thus, a non-functional pancreatic neuroendocrine
umor(PNET) was suspected after completion of this workup, and
istal pancreatectomy was conducted because of the possibility of
alignancy with the evidence that several slightly enlarged peri-
ancreatic lymph nodes were revealed on the MRI.
The surgical specimen contained a well-demarcated dark-red
oft nodule, 2.0 cm × 1.5 cm in size, surrounded by pancreatic tis-
ue on macroscopic appearance. Microscopically, the nodule was
omposed of lymphoid follicles and sinusoid-like structures, and
o apparent neoplastic component was founded (Fig. 2). Thus, an
ntrapancreatic accessory spleen was conﬁrmed by pathologic diag-
osis. The patient recovered from surgery without complications
nd was discharged ﬁve days later. Both the platelet count andty on T1-weighed MRI and higher intensity on both T2 and late phase of dynamic
enectomy two  years ago.
blood glucose level were within the normal limits on her follow-up
visit three months after the operation.
1.3. Discussion
IPAS is an uncommon congenital abnormality of the spleen with
the incidence around 2%.1 It is a benign lesion without indication
for operative intervention. However, in the majority of the cases
reported from the literature, IPASs were resected surgically with
no therapeutic effect, because they were difﬁcult to make an accu-
rate diagnosis preoperatively and were usually misdiagnosed as
hypervascular pancreatic neoplasms, such as PNETs.
The incidence of PNETs ranges up to 15% of pancreatic neo-
plasms in surgical series. Nearly 70% of PNETs are classiﬁed as
nonfunctional and all the PNET are malignant with the exception
of minute incipient neoplasms that occur in some syndromes like
type-1 multiple endocrine neoplasia.2,3 The initial imaging study
used to identify a PNET is a high-quality contrast-enhanced multi-
detector CT scan. PENTs are typically hyperdense and spherical on
the arterial phase of imaging. MRI  is more sensitive in the detec-
tion of smaller PNETs. PNETs are especially well visualized on T1
and T2-weighted images with fat suppression and typically have
high signal intensity on T2-weighted images.4 The multimodality
treatment for PENT includes surgery, hepatic-directed techniques
and systemic chemotherapy. The overall 10-year survival rate of
PNET ranges from 60% to 70% as reported.3
It is essential to differentiate nonfunctional PNETs from IPASs
because surgery is the preferable form of management for the
former while the latter usually require no operative intervention.
Unfortunately, there has been no special laboratory test with great
usefulness to conﬁrm or exclude the diagnosis of IPAS as yet.
Current image techniques may  provide useful information in thespleen, the IPAS more frequently shows homogeneous enhance-
ment and signal intensity than the PNET does on dynamic CT scans
and MRI  respectively. However, it remains difﬁcult to accurately
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valuate heterogeneous enhancement in IPAS smaller than 1 cm in
iameter by using contrast-enhanced CT or conventional MRI. Jang
t al.5 evaluated the diffusion-weighted MRI  (DW-MRI) imaging
n differentiation of an IPAS from a small solid pancreatic tumor
nd found that combined review of both DW-MRI with apparent
iffusion coefﬁcient maps and conventional morphologic MRI  can
revent the misdiagnosis of IPAS. Superparamagnetic iron oxide-
nhanced MRI  is a sensitive and speciﬁc modality for the diagnosis
f IPAS. Another noninvasive and speciﬁc test for detecting ectopic
plenic tissue is 99mTc scintigraphy which is based on the phago-
ytosis of 99mTc-labeled red blood cells by macrophages of the
eticuloendothelial system in the spleen.6
Except for the non-invasive methods mentioned above, EUS-
uided ﬁne-needle aspiration biopsy is an invasive approach to
onﬁrm the diagnosis of IPAS. Since Schreiner et al. reported the
rst case of IPAS diagnosed by EUS-FNA, there have been a few
ase reports of ectopic spleen diagnosed by EUS-FNA cytology.7
he predominant cytological features of IPAS include a poly-
orphous population of lymphocytes, traversing small vascular
tructures, and CD8 positive immunostaining of endothelial cells
n cell block sections. As immunostaining of CD8 is negative in
ystemic endothelial cell and hemangioma but speciﬁcally high-
ighted in endothelial cells of splenic sinuses, EUS-FNA with the
id of CD8 immunostaining may  make it possible to diagnose IPAS
reoperatively and thus avoid unnecessary surgery.7,8
Although a handful of IPASs have been reported, here we report
he ﬁrst case of IPAS after splenectomy according to the litera-
ure. The surgeons did not found any visible or palpable lesions
uring the previous operation. The IPAS had not been found until
he patient underwent MRI  for following examination after his
plenectomy two years later. This phenomenon can be explained as
ompensation according to the literature.9 In other words, the IPAS
n our case did exist unvisiblly and enlarged after her splenectomy.
e do not know whether the IPAS would continue to grow bigger
f not been resected, but our rare case should raise the awareness
f IPAS to avoid unnecessary surgery.
.4. Conclusion
IPAS has no indication for operative intervention in the most
ases, it is important to differentiate this benign lesion from pan-
reatic neoplasm to avoid unnecessary surgery. While the lesion is
o more than 2.5 cm in diameter and other accessory spleens show
round the splenic hilum, IPAS should be highly considered as a
ifferential diagnosis.
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